Abstract
We have investigated the mechanism and reactivity of covalent bond formation between cysteine-84 of the regulatory domain of cardiac troponin C and compounds containing a nitrile moiety similar to the calcium sensitizer levosimendan. The results of modifications to the levosimendan framework ranged from a large increase in covalent bond formation to complete inactivity. We present the biological activity of one of the most potent compounds. Limitations, including compound solubility and degradation at acidic pH, have prevented thorough investigation of the potential of these compounds. Our studies reveal the efficacious nature of the malononitrile moiety in targeting cNTnC and its potential in future cardiotonic drug design.
Original language | English |
---|---|
Pages (from-to) | 1007-1012 |
Number of pages | 6 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 10 |
Issue number | 6 |
DOIs | |
State | Published - Jun 13 2019 |
Bibliographical note
Publisher Copyright:© 2019 American Chemical Society.
Keywords
- Cardiac troponin C
- levosimendan
- malononitrile
- reversible thioimidate bond formation
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry